Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

"Amyloid-lowering treatments represent an important advance in the treatment of Alzheimer's disease but they are associated ...

What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...

Good afternoon and welcome to today's conference call for Omeros Corporation. (Operator Instructions) Please be advised that this call is being recorded at the company's request and a replay will be ...

Based on the insights collected to date, zaltenibart's clinical profile together with its low treatment burden of only four to six times per year is clearly differentiated from treatment options on ..

reinforces the best-in-class characteristics of our clinically validated anti-a-syn active immunotherapy for the treatment of ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling by more than 150 points on Thursday. The ...

The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) announced key resources and philanthropic capital to reshape scientific research fields and advance better ...

DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , a life sciences company focused on molecular hydrogen and AI diagnostics, is pleased to announce it has entered into a collaboration agreement ...